UNSPSC 51422503: Amcinafide

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0Q1D55E29, chemically known as s! 15,112 but generally known as amcinafide, which bears US NIH Compound Identifier 23747. European Medicines Agency schedules Amcinafide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05403MIG. The term AMCINAFIDE is an International Non-Proprietary Name.

UNSPSC 51422503 Amcinafide is a Commodity code that captures pharmaceutical products used in emergency response and harm-reduction programs, grounded in recent state and local solicitations for naloxone and drug deactivation systems. State and local health and human services agencies are the primary issuing bodies under this code, including county health departments and state pharmacy benefit programs. The scope of work encompasses procurement of pharmaceutical supplies for public health initiatives, with vendors expected to manage delivery logistics, maintain appropriate insurance coverage, and comply with workplace certification and federal regulatory requirements such as E-Verify and Clean Air Act adherence.

Recent activity spans Florida and Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the response deadline was July 26, 2023, at 2:00 pm. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs and vendor capabilities for implementing therapeutic pharmacy initiatives outside traditional pharmacy benefit manager arrangements. Neither solicitation specified set-aside designations for disadvantaged enterprises, though both required standard workplace compliance certifications.